UKIPO trademark

RETAHVERA

FiledUKIPOWord markClass 5

"RETAHVERA" is a word mark owned by Eli Lilly and Company, filed at the UKIPO on September 16, 2026. It is filed and waiting for examination and covers class 5 (Pharmaceuticals).

View Eli Lilly and Company portfolioGet this data via the API
Official UKIPO record
RETAHVERA
Word mark as filed with the UKIPO
Status
Filed
Since September 16, 2026
Filed
September 16, 2026
Registered
Not yet
Expires
Not recorded
Application no.
UK00004446067
Registration no.
UK00004446067
Office
UKIPO
Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns RETAHVERA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Eli Lilly and Company

LLY · United States

8,043 trademarks in the portfolioView company

Representative

Page, White & Farrer Limited

Page, White & Farrer Limited

Goods and services

What the mark covers

The products and services RETAHVERA is filed for, grouped by Nice class.

  • Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorder, alopecia, Alzheimer’s disease, asthma, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, cancer, cardiovascular disease, central nervous system diseases and disorders, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hearing loss, heart failure, infectious diseases, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, opioid use disorder, osteoarthritis, pain, Parkinson’s disease, psoriasis, psoriatic arthritis, pulmonary diseases, retinal disease, rheumatoid arthritis, tobacco use disorder, ulcerative colitis, vascular diseases and vision loss; pharmaceutical preparations for weight management; vaccines for human use.

FAQ

About RETAHVERA

Who owns the trademark "RETAHVERA"?

The UKIPO trademark "RETAHVERA" (application UK00004446067) is owned by Eli Lilly and Company.

What is the status of "RETAHVERA"?

Its status at the UKIPO is: filed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull RETAHVERA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a0ad6d-5660-732a-a76f-6609c9ad2e8e
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a0ad6d-5660-732a-a76f-6609c9ad2e8e",
  "object": "trademark",
  "mark_text": "RETAHVERA",
  "status": {
    "primary": "pending",
    "stage": "filed"
  },
  "office_code": "GB",
  "application_number": "UK00004446067",
  "filing_date": "2026-09-16",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Eli Lilly and Company",
      "entity_id": "ent_019eb749-c2e4-7669-8d85-00996fda299e"
    }
  ]
}